Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
D R NelsonJ Y Lau

Abstract

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes (CTL) have been shown to play a role in host defense and pathogenesis of chronic HCV infection. Our aim was to test the hypothesis that intrahepatic HCV-specific CTL activity may impact subsequent response to interferon alfa (IFN-alpha) therapy. Of the 37 patients that we have prospectively evaluated for HCV-specific CTL activity in liver, 21 received IFN therapy, and 19 completed a 6-month course and attended 6 to 18 months of follow-up. Intrahepatic CD8+ cells were isolated from liver biopsy tissue and tested against target cells expressing HCV antigens to determine intrahepatic CTL activity. The relationship between treatment response and HCV-specific CTL activity and other factors known to associate with response (genotype, viremia, histology) was analyzed. HCV-specific CTL activity was detected in 9 of 21 patients (and 9 of 19 who completed therapy). After 6 months of IFN therapy, 8 of 19 (42%) patients had normal serum alanine transaminase (ALT) (complete responders). After 18 months of follow-up, only 3 patients (16%) had a sustained biochemical response. Of the 9 patients with detectable HCV-specific CTL activity in their liver before treatment, 7 (78%) developed ...Continue Reading

References

Sep 1, 1981·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R G KnodellJ Wollman
Sep 1, 1993·European Journal of Immunology·G Stuhler, P Walden
Nov 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J Y LauJ C Scornik
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·A WeinerC M Walker
Mar 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R M HoffmannG R Pape
May 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P SimmondsD S Chen
Jan 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Leroux-RoelsG Maertens
Jul 1, 1996·The Journal of Infectious Diseases·J M PawlotskyD Dhumeaux
Apr 1, 1996·Journal of Clinical Microbiology·J DetmerR Sánchez-Pescador
Mar 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K HiroishiM Imawari
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G MissaleC Ferrari

❮ Previous
Next ❯

Citations

Jan 27, 2004·Biochemical and Biophysical Research Communications·Nelson Acosta-RiveroJuan Morales-Grillo
Dec 13, 2005·Cellular Immunology·Maria H NikolovaArmand Bensussan
Jul 2, 1999·Antiviral Research·R P González-PeraltaT L Wright
Nov 3, 2001·Journal of Hepatology·M BerenguerT L Wright
Jan 6, 2000·Journal of Hepatology·C FerrariF Fiaccadori
Jan 6, 2000·Journal of Hepatology·H C ThomasS D Taylor-Robinson
Nov 15, 2000·La Revue de médecine interne·D Emilie, P Galanaud
Jan 4, 2001·Microbes and Infection·D R TaylorM M Lai
Oct 18, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·P Ferenci
Aug 19, 2005·Nature·Michael Houghton, Sergio Abrignani
Aug 8, 2002·Clinical and Experimental Immunology·A KaserH Tilg
Apr 12, 2000·Journal of Viral Hepatitis·S Sherlock
Jun 10, 2000·Journal of Viral Hepatitis·L A KondiliA Mele
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C A SchirrenG R Pape
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T F BaumertT J Liang
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Johnson Y N LauZhi Hong
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Amalia PennaCarlo Ferrari
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anouk T DevWilliam Sievert
Sep 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David R NelsonGary L Davis
Jun 13, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Scott J CotlerMilton W Taylor
Jun 28, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Tony WangScott D Seiwert
Feb 24, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·F LechnerP Klenerman
Jul 16, 2011·Hepatitis Research and Treatment·Yasuteru KondoTooru Shimosegawa
Jun 11, 2008·Journal of Immune Based Therapies and Vaccines·Curtis L CooperHeather L Davis
Apr 12, 2003·Fukushima Journal of Medical Science·Hiromasa OhiraReiji Kasukawa
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·X S HeH B Greenberg
Nov 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T BergE Schreier
Feb 6, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·F Xavier López-LabradorMiguel Gobernado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.